Skip to main content
IC
Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.38
+0.28 (3.46%)
At close: May 12, 2025, 4:00 PM
7.72
-0.66 (-7.88%)
After-hours: May 12, 2025, 4:00 PM EDT

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 58.35K CHF in the quarter ending September 30, 2024, a decrease of -82.28%. This brings the company's revenue in the last twelve months to 592.36K, down -71.27% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.

Revenue (ttm)
592.36K CHF
Revenue Growth
-71.27%
P/S Ratio
9.92
Revenue / Employee
25,755 CHF
Employees
23
Market Cap
6.96M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.65M202.11K13.99%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 20192.83M-3.87M-57.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

ADXN News

More News